These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34762265)

  • 21. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
    Pár A
    Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
    Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
    J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis.
    Choi WM; Choi J; Lim YS
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):246-258.e9. PubMed ID: 32407970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and secondary prevention of liver cancer caused by HBV.
    Blumberg BS
    Front Biosci (Schol Ed); 2010 Jan; 2(2):756-63. PubMed ID: 20036981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
    Liu K; Choi J; Le A; Yip TC; Wong VW; Chan SL; Chan HL; Nguyen MH; Lim YS; Wong GL
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1037-1048. PubMed ID: 31524304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hepatitis B virus-related hepatocellular carcinoma.
    Lok AS
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S303-9. PubMed ID: 15508098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-induced hepatocellular carcinoma with special emphasis on HBV.
    Wang M; Xi D; Ning Q
    Hepatol Int; 2017 Mar; 11(2):171-180. PubMed ID: 28097530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta-analysis.
    Giri S; Agrawal D; Afzalpurkar S; Gopan A; Angadi S; Sundaram S
    J Viral Hepat; 2023 Feb; 30(2):108-115. PubMed ID: 36321967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.
    Dave S; Park S; Murad MH; Barnard A; Prokop L; Adams LA; Singh S; Loomba R
    Hepatology; 2021 Jan; 73(1):68-78. PubMed ID: 32277491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.
    Lu T; Seto WK; Zhu RX; Lai CL; Yuen MF
    World J Gastroenterol; 2013 Dec; 19(47):8887-94. PubMed ID: 24379612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy.
    Halegoua-De Marzio D; Hann HW
    Minerva Gastroenterol Dietol; 2014 Sep; 60(3):191-200. PubMed ID: 25000955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.
    Kim SU; Seo YS; Lee HA; Kim MN; Lee EJ; Shin HJ; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):832-837. PubMed ID: 31988073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and therapy of hepatitis B virus infection: Czech national guidelines].
    Husa P; Šperl J; Urbánek P; Fraňková S; Plíšek S; Kümpel P; RoŽnovský L
    Klin Mikrobiol Infekc Lek; 2017 Dec; 23(4):148-164. PubMed ID: 29378384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma.
    Lee SW; Choi J; Kim SU; Lim YS
    Clin Mol Hepatol; 2021 Jul; 27(3):402-412. PubMed ID: 34157830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Timing and selection of antiviral therapy with nucleos(t)ide analogues for prevention of hepatitis B virus-related HCC].
    Han C; Lai PP; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):827-830. PubMed ID: 31941235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting.
    Idilman R; Gunsar F; Koruk M; Keskin O; Meral CE; Gulsen M; Elhan AH; Akarca US; Yurdaydin C
    J Viral Hepat; 2015 May; 22(5):504-10. PubMed ID: 25431108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.